Skip to content

Continuous Infusion for Pain Relief

Comparaison of Continuous Infusion of Local Anesthetic and Intrathecal Morphine for Pain Management in Elective Caeserean Section

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02711072
Enrollment
60
Registered
2016-03-17
Start date
2016-03-31
Completion date
2016-03-31
Last updated
2016-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caeserian Section, Local Anesthetic, Regional Anesthesia

Brief summary

SPINAL anesthesia is commonly used for cesarean section, and it has become a popular practice to add opioids to spinal solutions to enhance and prolong intraoperative and postoperative analgesia. high incidence of side effects was noted. is there any alternative?

Interventions

DRUGcontrol group

spinal anesthesia with 10 mg hyperbaric Bupivacaïne 0,5% + 2,5 µ Sufentanyl + 100 µ of intrathecal Morphine+ infiltration catheter with saline 5 ml/h

DRUGinfiltration group

spinal anesthesia with 10 mg hyperbaric Bupivacaïne 0,5% + 2,5 µ Sufentanyl + 1ml of saline + infiltration catheter with 5 ml/h of Bupivacaïne 0,125%.

Sponsors

Tunisian Military Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* ASA physical status I-II * 18-45 years of age, inclusive * elective caeserean section under spinal anesthesia

Exclusion criteria

* \- contraindications to spinal anesthesia (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the area) * existing neurological deficit * inability to understand the informed consent and demands of the study

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogic Scaleuntil 48 hours postoperativequality of postoperative analgesia

Secondary

MeasureTime frame
occurrence of complications48 hours post operative
total dose of morphine consumption in mgduring 48 hours post operative

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026